These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37410387)

  • 41. Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.
    Liu HJ; Krymskaya VP; Henske EP
    Chest; 2019 Dec; 156(6):1062-1067. PubMed ID: 31437431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis.
    Glasgow CG; Pacheco-Rodriguez G; Steagall WK; Haughey ME; Julien-Williams PA; Stylianou MP; Gochuico BR; Moss J
    Chest; 2018 Feb; 153(2):339-348. PubMed ID: 28576630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.
    Liu HJ; Lizotte PH; Du H; Speranza MC; Lam HC; Vaughan S; Alesi N; Wong KK; Freeman GJ; Sharpe AH; Henske EP
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin growth factor binding protein 2 mediates the progression of lymphangioleiomyomatosis.
    Li X; Liu X; Zhang L; Li C; Zhang E; Ma W; Fan Q; Yu JJ
    Oncotarget; 2017 May; 8(22):36628-36638. PubMed ID: 28410230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.
    Valianou M; Cox AM; Pichette B; Hartley S; Paladhi UR; Astrinidis A
    Cell Cycle; 2015; 14(3):399-407. PubMed ID: 25565629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2.
    Goncharova EA; Goncharov DA; Spaits M; Noonan DJ; Talovskaya E; Eszterhas A; Krymskaya VP
    Am J Respir Cell Mol Biol; 2006 May; 34(5):561-72. PubMed ID: 16424383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary Lymphangioleiomyomatosis originates in the pleural mesothelial cell population.
    Clements D; Miller S; Johnson SR
    Med Hypotheses; 2020 Aug; 141():109703. PubMed ID: 32276237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM).
    Liu J; Zhao W; Ou X; Zhao Z; Hu C; Sun M; Liu F; Deng J; Gu W; An J; Zhang Q; Zhang X; Xie J; Li S; Chen R; Yu S; Zhong N
    PLoS One; 2019; 14(12):e0226400. PubMed ID: 31856217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors.
    Alayev A; Salamon RS; Sun Y; Schwartz NS; Li C; Yu JJ; Holz MK
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):637-46. PubMed ID: 25844891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [
    Verwer EE; Kavanagh TR; Mischler WJ; Feng Y; Takahashi K; Wang S; Shoup TM; Neelamegam R; Yang J; Guehl NJ; Ran C; Massefski W; Cui Y; El-Chemaly S; Sadow PM; Oldham WM; Kijewski MF; El Fakhri G; Normandin MD; Priolo C
    Clin Cancer Res; 2018 Dec; 24(23):5925-5938. PubMed ID: 30054282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mast-Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis.
    Babaei-Jadidi R; Dongre A; Miller S; Castellanos Uribe M; Stewart ID; Thompson ZM; Nateri AS; Bradding P; May ST; Clements D; Johnson SR
    Am J Respir Crit Care Med; 2021 Aug; 204(4):431-444. PubMed ID: 33882264
    [No Abstract]   [Full Text] [Related]  

  • 52. Lymphangioleiomyomatosis and tuberous sclerosis complex.
    Chorianopoulos D; Stratakos G
    Lung; 2008; 186(4):197-207. PubMed ID: 18408969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis.
    Gu X; Yu JJ; Ilter D; Blenis N; Henske EP; Blenis J
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14960-5. PubMed ID: 23983265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
    Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
    J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.
    Taveira-DaSilva AM; Moss J
    Expert Opin Orphan Drugs; 2016; 4(4):369-378. PubMed ID: 27833825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of Growth of TSC2-Null Cells by a PI3K/mTOR Inhibitor but Not by a Selective MNK1/2 Inhibitor.
    Evans JF; Rue RW; Mukhitov AR; Obraztsova K; Smith CJ; Krymskaya VP
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31878201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current understanding and perspectives of lymphangioleiomyomatosis].
    Seyama K; Ando K; Hoshika Y; Suzuki Y; Takekawa H
    Nihon Rinsho; 2013 Jun; 71(6):1103-8. PubMed ID: 23855221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic Impact of Rapamycin (Sirolimus) and B-Estradiol Using Mouse Embryonic Fibroblasts as a Model for Lymphangioleiomyomatosis.
    Marsh KM; Schipper D; Ferng AS; Johnson K; Fisher J; Knapp S; Dicken D; Khalpey Z
    Lung; 2017 Aug; 195(4):425-430. PubMed ID: 28577037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs.
    Prizant H; Sen A; Light A; Cho SN; DeMayo FJ; Lydon JP; Hammes SR
    Mol Endocrinol; 2013 Sep; 27(9):1403-14. PubMed ID: 23820898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.